Sarepta Therapeutics, Inc. logo

SRPTSarepta Therapeutics, Inc.

SRPT Stock Price, Valuation & Chart | Sarepta Therapeutics, Inc.

Compare
$13.330-0.84 (-5.93%)

At close · 20 Nov 2026, 09:00 pm

SRPT Historical price chart

SRPT Key Stats

Fair value estimate
Disclaimer

General advice only. Model estimate, not a price target or a recommendation to buy, sell or hold. Not based on your objectives, financial situation or needs: consider the product disclosure statement and your own circumstances. Alphacentric Technology Pty Ltd t/a Tickerplace is a CAR (No. 001324046) of MF & Co. Asset Management Pty Ltd (AFSL 520442).

Market Capitalization1.43B
PE Ratio-22.22
EPS-0.6
Trading Volume2.23M
Today's High/Low14.47/13.26
Dividend Yield0.00
52 Week High/Low24.68/13.26
Shares Outstanding107.24M

Price and calculated levels

A preview of the SRPT chart Pro members see. Dollar amounts stay locked. Each line is a calculated margin of safety or premium price, not a forecast.

Price $•••$•••+100%$•••+90%$•••+80%$•••+60%$•••+40%$•••+20%$•••Fair value$•••−20%$•••−30%$•••−40%$•••−50%$•••−60%
SRPT Financial Statement
SRPT Analyst ratings
SRPT Analysis & performance metrics

SRPT Company profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other…

SRPT Management team

Management
Louise R. Rodino-Klapac Ph.D.
Executive Vice President, Chief Scientific Officer and Head of Research & Development
Dallan Murray
Executive Vice President & Chief Customer Officer
Cristin L. Rothfuss J.D.
Executive Vice President, Chief General Counsel & Corporate Secretary
Diane L. Berry Ph.D.
Executive Vice President and Chief of Global Policy & Advocacy Officer
Francesca T. NolanCTO
Executive Director of Investor Relations and Corporate Communications
Ian Michael EstepanCFO
Executive Vice President & Chief Financial Officer
Bilal Arif
Executive Vice President & Chief Technical Operations Officer
Douglas S. Ingram Esq.CEO
President, Chief Executive Officer & Director
Total 8 executives

SRPT Frequently asked questions

What is Sarepta Therapeutics, Inc. (SRPT) Stock Price?

Current stock price of Sarepta Therapeutics, Inc. (SRPT) stock is $13.330. The stock price is -5.93% lower in the session. The intraday range can be seen from this page. Volume of Sarepta Therapeutics, Inc. (SRPT) stock is 2.23M.

Last updated at 20 Nov 2026, 09:00 pm.

Why is the Sarepta Therapeutics, Inc. (SRPT) stock price going up or down today?

The stock price of Sarepta Therapeutics, Inc. (SRPT) can change with earnings, company news, and overall market sentiment. Sarepta Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Sarepta Therapeutics, Inc. stock expensive at its current price?

Whether Sarepta Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SRPT on this page is -22.22. EPS on this page is -0.60. Compare those figures with peers and growth expectations before deciding if the current Sarepta Therapeutics, Inc. price is justified.

How has the stock price of Sarepta Therapeutics, Inc. (SRPT) performed historically?

Historical performance for Sarepta Therapeutics, Inc. (SRPT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SRPT reacted to past earnings and market events.

Should I buy Sarepta Therapeutics, Inc. (SRPT) stock, at this price?

Buying Sarepta Therapeutics, Inc. (SRPT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.